K. Ahmed, B. Gupta, Jivesh Bansal, N. Singh, Ashok Kumar
{"title":"全球阿尔朱那终末植物研究:2004-18年出版物的定量和定性评估","authors":"K. Ahmed, B. Gupta, Jivesh Bansal, N. Singh, Ashok Kumar","doi":"10.5530/PHREV.2020.14.8","DOIUrl":null,"url":null,"abstract":"Cite this article: Ahmed KKM, Gupta BM, Singh N, Kumar A. Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18. Pharmacog Rev. 2020;14(27):45-52. ABSTRACT 683 global research publications on Terminalia arjuna were derived from the Scopus database during the last 22 years (1997-18) with a view to study its quantitative and qualitative aspects. The global publication data showed that the average annual and eleven-year cumulative global output of Terminalia arjuna research registered 8.33% and 169.19% growth. The plant global citation impact averaged to 16.92 citations per paper (CPP) in twenty-two years, which decreased from 36.02 CPP to 9.82 CPP from 1997-07 to 2008-18. The top 10 most productive countries together accounted for more than 100.0% global publication share and 99.13% global citation share during 1997-18. India, alone accounting for the highest and largest publication share of 82.43% and other 9 countries from 1.02% to 5.27% during 1997-18. Five out of top 10 countries, namely Iran (2.85), U.K. (1.94), Japan (1.22), USA (1.16) and Pakistan (1.09) registered relative citation index above the global average of 0.97. Pharmacology, toxicology and pharmaceutics, among seven broad subjects, contributed the largest publications share of 50.51%, followed by medicine (30.31%), biochemistry, genetics and molecular biology (26.52%), agricultural and biological sciences (21.52%) and other 3 sub-fields contribution varying from 4.54% to 10.83% during 1997-18. 239 global organizations and 309 global authors in global Terminalia arjuna research during 1997-18, of which the 15 most productive global organizations and authors together contributed 30.16% and 15.37% global publication share and 36.87% and 20.68% global citation share respectively during 1997-18. Hamdard University, Delhi, India (with 30 papers), Banaras Hindu University, Varanasi, India (22 papers) and All India Institute of Medical Sciences, New Delhi, India (19 papers), S. Dwivedi (with 11 papers), S.K. Maulik (10 papers) and P.C. Sil (8 papers) and Journal of Ethnopharmacology (with 26 papers), International Journal of Pharmacy and Pharmaceutical Sciences (15 papers), Asian Journal of Pharmaceutical and Clinical Research (14 papers) were the three leading organizations, authors and journals reporting global research in Terminalia arjuna during 199718.","PeriodicalId":74432,"journal":{"name":"Pharmacognosy reviews","volume":"254 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18\",\"authors\":\"K. Ahmed, B. Gupta, Jivesh Bansal, N. Singh, Ashok Kumar\",\"doi\":\"10.5530/PHREV.2020.14.8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cite this article: Ahmed KKM, Gupta BM, Singh N, Kumar A. Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18. Pharmacog Rev. 2020;14(27):45-52. ABSTRACT 683 global research publications on Terminalia arjuna were derived from the Scopus database during the last 22 years (1997-18) with a view to study its quantitative and qualitative aspects. The global publication data showed that the average annual and eleven-year cumulative global output of Terminalia arjuna research registered 8.33% and 169.19% growth. The plant global citation impact averaged to 16.92 citations per paper (CPP) in twenty-two years, which decreased from 36.02 CPP to 9.82 CPP from 1997-07 to 2008-18. The top 10 most productive countries together accounted for more than 100.0% global publication share and 99.13% global citation share during 1997-18. India, alone accounting for the highest and largest publication share of 82.43% and other 9 countries from 1.02% to 5.27% during 1997-18. Five out of top 10 countries, namely Iran (2.85), U.K. (1.94), Japan (1.22), USA (1.16) and Pakistan (1.09) registered relative citation index above the global average of 0.97. Pharmacology, toxicology and pharmaceutics, among seven broad subjects, contributed the largest publications share of 50.51%, followed by medicine (30.31%), biochemistry, genetics and molecular biology (26.52%), agricultural and biological sciences (21.52%) and other 3 sub-fields contribution varying from 4.54% to 10.83% during 1997-18. 239 global organizations and 309 global authors in global Terminalia arjuna research during 1997-18, of which the 15 most productive global organizations and authors together contributed 30.16% and 15.37% global publication share and 36.87% and 20.68% global citation share respectively during 1997-18. Hamdard University, Delhi, India (with 30 papers), Banaras Hindu University, Varanasi, India (22 papers) and All India Institute of Medical Sciences, New Delhi, India (19 papers), S. Dwivedi (with 11 papers), S.K. Maulik (10 papers) and P.C. Sil (8 papers) and Journal of Ethnopharmacology (with 26 papers), International Journal of Pharmacy and Pharmaceutical Sciences (15 papers), Asian Journal of Pharmaceutical and Clinical Research (14 papers) were the three leading organizations, authors and journals reporting global research in Terminalia arjuna during 199718.\",\"PeriodicalId\":74432,\"journal\":{\"name\":\"Pharmacognosy reviews\",\"volume\":\"254 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacognosy reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5530/PHREV.2020.14.8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacognosy reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/PHREV.2020.14.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
摘要
引用本文:Ahmed KKM, Gupta BM, Singh N, Kumar A. arjuna Terminalia的全球研究:2004-18年的定量和定性评估。药理学杂志,2020;14(27):45-52。摘要:本文从Scopus数据库中检索了近22年(1997-18年)全球683篇关于Terminalia arjuna的研究论文,目的是对其进行定量和定性研究。全球发表数据显示,全球平均年和11年累计阿朱那研究产出分别增长8.33%和169.19%。22年间,植物全球引文影响平均为16.92次/篇,从1997-07年的36.02次/篇下降到2008-18年的9.82次/篇。在1997-18年期间,前10个生产力最高的国家合计占全球出版物份额的100.0%以上,全球引用份额的99.13%以上。在1997-18年间,仅印度就占了最高和最大的出版份额82.43%,其他9个国家从1.02%上升到5.27%。在排名前10位的国家中,伊朗(2.85)、英国(1.94)、日本(1.22)、美国(1.16)、巴基斯坦(1.09)等5个国家的相对引文指数超过了全球平均水平0.97。药理学、毒理学和药剂学是7个大学科中发表论文最多的,为50.51%,其次是医学(30.31%)、生物化学、遗传与分子生物学(26.52%)、农业与生物科学(21.52%),其他3个子学科的发表论文比例在4.54% - 10.83%之间。1997-18年间,共有239个全球组织和309位全球作者参与了全球阿朱那论研究,其中15个全球组织和作者的全球发表份额分别为30.16%和15.37%,全球引用份额分别为36.87%和20.68%。印度德里的Hamdard大学(30篇论文)、印度瓦拉纳西的Banaras Hindu大学(22篇论文)和印度新德里的全印度医学科学研究所(19篇论文)、S. Dwivedi(11篇论文)、S.K. Maulik(10篇论文)、P.C. Sil(8篇论文)和《民族药理学杂志》(26篇论文)、《国际药学与药物科学杂志》(15篇论文)、《亚洲药物与临床研究杂志》(14篇论文)是三个主要机构。作者和期刊报道了1997 - 18年全球关于阿尔朱那终末植物的研究。
Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18
Cite this article: Ahmed KKM, Gupta BM, Singh N, Kumar A. Global Research on Terminalia arjuna: A Quantitative and Qualitative Assessment of Publications during 2004-18. Pharmacog Rev. 2020;14(27):45-52. ABSTRACT 683 global research publications on Terminalia arjuna were derived from the Scopus database during the last 22 years (1997-18) with a view to study its quantitative and qualitative aspects. The global publication data showed that the average annual and eleven-year cumulative global output of Terminalia arjuna research registered 8.33% and 169.19% growth. The plant global citation impact averaged to 16.92 citations per paper (CPP) in twenty-two years, which decreased from 36.02 CPP to 9.82 CPP from 1997-07 to 2008-18. The top 10 most productive countries together accounted for more than 100.0% global publication share and 99.13% global citation share during 1997-18. India, alone accounting for the highest and largest publication share of 82.43% and other 9 countries from 1.02% to 5.27% during 1997-18. Five out of top 10 countries, namely Iran (2.85), U.K. (1.94), Japan (1.22), USA (1.16) and Pakistan (1.09) registered relative citation index above the global average of 0.97. Pharmacology, toxicology and pharmaceutics, among seven broad subjects, contributed the largest publications share of 50.51%, followed by medicine (30.31%), biochemistry, genetics and molecular biology (26.52%), agricultural and biological sciences (21.52%) and other 3 sub-fields contribution varying from 4.54% to 10.83% during 1997-18. 239 global organizations and 309 global authors in global Terminalia arjuna research during 1997-18, of which the 15 most productive global organizations and authors together contributed 30.16% and 15.37% global publication share and 36.87% and 20.68% global citation share respectively during 1997-18. Hamdard University, Delhi, India (with 30 papers), Banaras Hindu University, Varanasi, India (22 papers) and All India Institute of Medical Sciences, New Delhi, India (19 papers), S. Dwivedi (with 11 papers), S.K. Maulik (10 papers) and P.C. Sil (8 papers) and Journal of Ethnopharmacology (with 26 papers), International Journal of Pharmacy and Pharmaceutical Sciences (15 papers), Asian Journal of Pharmaceutical and Clinical Research (14 papers) were the three leading organizations, authors and journals reporting global research in Terminalia arjuna during 199718.